Hannes M Schröder

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

A. Kerstan, Philipp Schrüfer, M. Goebeler, 2020, Cytotherapy.

New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Deficiency: Review from the European Vision Institute Special Interest Focus Group Meeting

L. Schmetterer, S. Fauser, J. Horstmann, 2020, Ophthalmic Research.

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

A. Kerstan, M. Jünger, G. Daeschlein, 2021, JID innovations.

Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues

M. Frank, E. Niebergall-Roth, M. Kluth, 2023, Cells.

AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome

P. Robinson, M. Hecker, M. Karck, 2017, Molecular therapy. Nucleic acids.

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

S. Sel, B. Ksander, J. Chodosh, 2020, Stem cell research & therapy.

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

A. Kerstan, M. Jünger, G. Daeschlein, 2022, Stem Cell Research & Therapy.

Transdermal drug targeting and functional imaging of tumor blood vessels in the mouse auricle

M. Hecker, T. Korff, D. Komljenovic, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.